CNP:NYSECenterPoint Energy, Inc (Holding Co) Analysis
Data as of 2026-03-10 - not real-time
$43.66
Latest Price
3/10Risk
Risk Level: Low
Executive Summary
CenterPoint Energy is trading at $43.66, comfortably above its 20‑day ($42.84) and 50‑day ($40.58) moving averages, indicating short‑term bullish momentum, yet the RSI of 66 suggests the stock is approaching overbought territory. The MACD histogram has turned negative and volume is on a decreasing trend, while the price sits just below the 52‑week high of $44.04, hinting at limited upside in the near term.
Fundamentally, the company posts solid revenue growth of 10.7% and a dividend yield of 2.12% with a payout ratio near 55%, but a DCF‑derived fair value of roughly $23.5 signals significant overvaluation. Recent earnings missed consensus and the announcement of a $600 million convertible note offering add short‑term pressure, whereas the regulated utility franchise and a growing dividend provide a defensive, long‑run foundation.
Fundamentally, the company posts solid revenue growth of 10.7% and a dividend yield of 2.12% with a payout ratio near 55%, but a DCF‑derived fair value of roughly $23.5 signals significant overvaluation. Recent earnings missed consensus and the announcement of a $600 million convertible note offering add short‑term pressure, whereas the regulated utility franchise and a growing dividend provide a defensive, long‑run foundation.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Recent earnings miss versus consensus
- RSI approaching overbought levels
- Decreasing volume and bearish MACD histogram
Medium Term
1–3 yearsCautious
Model confidence: 7/10
Key Factors
- Significant gap between market price and DCF fair value
- Potential dilution from the $600 million convertible note offering
- High debt load relative to equity
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Stable, regulated revenue streams across multiple states
- Attractive dividend yield with sustainable payout
- Defensive utility sector positioning in a low‑beta environment
Key Metrics & Analysis
Financial Health
Revenue Growth10.70%
Profit Margin11.24%
P/E Ratio27.3
ROE9.64%
ROA2.89%
Debt/Equity206.60
P/B Ratio2.6
Op. Cash Flow$2.5B
Free Cash Flow$-3899749888
Industry P/E20.8
Technical Analysis
TrendBullish
RSI66.5
Support$40.10
Resistance$44.04
MA 20$42.84
MA 50$40.58
MA 200$38.70
MACDBearish
VolumeDecreasing
Fear & Greed Index81.48
Valuation
Fair Value$23.49
Target Price$44.50
Upside/Downside1.92%
GradeOvervalued
TypeBlend
Dividend Yield2.12%
Risk Assessment
Beta0.14
Volatility15.19%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.